Akari Therapeutics Plc

AKTX - CIK 0001541157

Market cap-

Rank-

SEC filings710

Akari Therapeutics Plc revenue by year

Akari Therapeutics Plc (AKTX) reported revenue of $367.88K for fiscal year 2023, as filed in its audited annual report with the SEC.

AKTX annual revenue

Fiscal year	Revenue	Change
FY 2023	$367.88K	-39.5%
FY 2022	$607.68K	-

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.